First Manhattan
AKBA icon

First Manhattan’s Akebia Therapeutics AKBA Stock Holding History

First Manhattan’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-835,900
Closed -$11.4M – 1322
2020
Q2 		$11.4M Buy
+835,900
New +$8.65M 0.07% 137
2020
Q1 		– Sell
-123,900
Closed -$783K – 1359
2019
Q4 		$783K Hold
123,900
– – ﹤0.01% 452
2019
Q3 		$485K Buy
+123,900
New +$531K ﹤0.01% 529
2019
Q1 		– Sell
-260,200
Closed -$1.44M – 1379
2018
Q4 		$1.44M Sell
260,200
-541,166
-68% -$4.23M 0.01% 382
2018
Q3 		$7.08M Buy
801,366
+236,300
+42% +$2.11M 0.04% 226
2018
Q2 		$5.64M Hold
565,066
– – 0.03% 245
2018
Q1 		$5.38M Hold
565,066
– – 0.03% 245
2017
Q4 		$8.4M Sell
565,066
-347,434
-38% -$5.76M 0.05% 211
2017
Q3 		$17.9M Sell
912,500
-276,000
-23% -$4.24M 0.1% 138
2017
Q2 		$17.1M Buy
1,188,500
+150,000
+14% +$1.9M 0.1% 140
2017
Q1 		$9.55M Hold
1,038,500
– – 0.06% 178
2016
Q4 		$10.8M Sell
1,038,500
-666,800
-39% -$5.74M 0.07% 168
2016
Q3 		$15.4M Sell
1,705,300
-159,300
-9% -$1.35M 0.09% 141
2016
Q2 		$13.9M Sell
1,864,600
-1,200
-0.1% -$10.5K 0.09% 156
2016
Q1 		$16.8M Buy
1,865,800
+1,071,996
+135% +$8.69M 0.1% 130
2015
Q4 		$10.3M Buy
793,804
+662,500
+505% +$6.76M 0.06% 168
2015
Q3 		$1.27M Buy
+131,304
New +$1.2M 0.01% 391

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Manhattan's AKBA Position: Q3 2020 in Review

First Manhattan sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 835,900 shares — an estimated $11.4M sold.

First Manhattan first reported a position in AKBA in Q3 2015 and held it in 17 quarters. The position peaked at $17.9M in Q3 2017. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • First Manhattan reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • First Manhattan sold 835,900 Akebia Therapeutics shares in Q3 2020, an estimated $11.4M.
  • First Manhattan first reported a position in Akebia Therapeutics in Q3 2015 and held it in 17 quarters.
  • First Manhattan's Akebia Therapeutics position peaked at $17.9M in Q3 2017.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.